Center Laboratories, Inc. (4123) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Center Laboratories, Inc. (4123:TWSE), powered by AI.

Current Price
$37.65
Sector
Healthcare
What is the Center Laboratories, Inc. stock price forecast?

Center Laboratories, Inc. is currently trading at $37.65. View real-time AI analysis on Alpha Lenz.

What is Center Laboratories, Inc. insider trading activity?

View the latest insider trading data for Center Laboratories, Inc. on Alpha Lenz.

What is Center Laboratories, Inc.'s P/E ratio?

View Center Laboratories, Inc.'s valuation metrics on Alpha Lenz.

Center Laboratories, Inc.

TWSE · 4123
NT$37.65+0.00(+0.00%)
Ask about Center Laboratories, Inc.'s future dividend policy...
Alpha Chat Insight

Center Laboratories, Inc.'s ROE is 41.9%. Explore profitability and growth together.

Ask for details

Company Overview

Center Laboratories, Inc. is a pharmaceutical company specializing in the development, manufacturing, and distribution of medications primarily within Taiwan and expanding internationally. The firm is recognized for a broad product portfolio that includes general pharmaceuticals such as antipyretics, analgesics, bronchodilators, anti-inflammatory and anti-allergy preparations, as well as a specialized focus on central nervous system treatments for conditions like cerebrovascular disease, dementia, and epilepsy. Additionally, the company is involved in drug research, cell therapy, biotechnology, and has interests in emerging sectors like hydrogen energy and dairy. Founded in 1959 and headquartered in Taipei City, Center Laboratories plays an important role in the healthcare industry, addressing diverse medical needs through both specialty and generic drug lines. The company's activities support advancements in pharmaceutical research and patient care, impacting healthcare outcomes across Taiwan and regional markets. Its consistent revenue growth, diversified operations, and commitment to research underline its significance within the Asian pharmaceutical landscape.

CEOMs. Su-Chi Wang
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$1.52BRevenue
0.00Shares Out
0Employees

Margins

40.97%Gross
-17.52%EBITDA
-23.88%Operating
763.01%Pre-Tax
614.88%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

25.46%Rev 3Yr
16.16%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
13.79%Net Inc 5Yr

Returns

30.99%ROA
41.86%ROE
39.14%ROIC

Financial Health

NT$237.56MCash & Cash Equivalents
NT$7.90BNet Debt
30.74%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Center Laboratories, Inc. (ticker: 4123) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic).

The current price is 37.65 with a P/E ratio of -x and P/B of -x.

ROE is 41.86% and operating margin is -23.88%. Annual revenue is $1.5B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Center Laboratories, Inc. (4123) Stock Forecast 2026 $37.65 — Price, Financials & Analyst Targets | Alpha Lenz